Systematic review evaluates lung ultrasound's diagnostic role in meconium aspiration syndrome in neonates, suggesting its potential as first-line imaging.
The aim of the study: Meconium aspiration syndrome (MAS) remains an important cause of neonatal respiratory distress and is traditionally diagnosed using clinical criteria supported by chest X-ray. Lung ultrasound (LUS) is a radiation-free, bedside imaging modality increasingly used in neonatal lung diseases. The objective of this systematic review is to evaluate the diagnostic role of LUS in neonates with MAS. Materials and methods: A systematic literature search was conducted in PubMed and Google Scholar in accordance with the PRISMA 2020 guidelines. Original studies involving neonates with MAS and reporting MAS-specific LUS data were included. Studies were excluded if they were non-English, animal studies, lacked original data, involved non-MAS populations or focused on therapy guidance rather than diagnosis. Results: Five studies met the inclusion criteria. Across the included studies, LUS demonstrated high diagnostic performance for MAS, with reported sensitivity ranging from 90% to 100% and specificity 99.3% to 100%. Characteristic LUS findings included lung consolidations with air bronchogram, pleural line abnormalities, disappearance of A-lines and alveolar-interstitial syndrome. Conclusions: LUS appears to be a reliable diagnostic tool for MAS and offers important advantages including absence of ionizing radiation and bedside applicability. It may be considered a first-line imaging modality in infants with suspected MAS, with chest X-ray reserved for cases of diagnostic uncertainty. Further studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Mazurek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: